- Assistant Professor, CWRU School of Medicine
- Amyotrophic Lateral Sclerosis (ALS)
- Carpal Tunnel Syndrome
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Electromyography (EMG)
- Entrapment Neuropathies
- Myasthenia Gravis (MG)
- Nerve Conduction Studies (NCS)
- Peripheral Neuropathies
- Ulnar Neuropathies
Patient Satisfaction Reviews
4.6 out of 5
Patient Comments (9)
Reviewed On 8/4/2020
Dr. Sawlani was extremely competent and helpful. I am very satisfied with her performance.
Reviewed On 6/1/2020
I love dr swalani
Reviewed On 5/1/2020
I love my provider!
Reviewed On 2/21/2020
Provider was a specialist conducting an EMG. experience was very good.
Reviewed On 2/6/2020
the service was fast and professional
Reviewed On 12/9/2019
Had a good exchange of information and received a good plan for going forward with treatment.
Reviewed On 11/18/2019
Reviewed On 11/16/2019
Dr Sawlani always addresses all of my concerns and explains her plan for my care moving forward and makes sure I am comfortable with everything. I am blessed to be in her care.
Reviewed On 10/3/2019
I was very reassured after seeing Dr S for a foot problem after cardio ablation. Left with a plan and a follow up appointment. She is wonderful.
- Neuromuscular Medicine - American Board of Psychiatry and Neurology
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Neuromuscular Disease
Neuromuscular Disease - Brigham And Women's Hospital (2015 - 2016)
Residency | Neurology
Neurology - Uh Case Medical Center (2011 - 2015)
Indiana University School Of Medicine (2011)
Northwestern University (2007)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Komal Sawlani did not disclose any Outside Relationships with Industry.